Background: Hepatitis B virus infection is an important global health problem and India accounts for 10-15% of the entire pool of HBV carriers of the world. Hepatitis B virus infection during pregnancy is associated with a high risk of maternal complications and has been reported as a leading cause of maternal mortality. Furthermore, the strong possibility of vertical transmission lends importance to diagnosing acute or chronic hepatitis B virus infection in pregnant women and justifies mandatory antepartum serum HBsAg screening.
Introduction
Hepatitis B virus infection is an important global health problem and India has over 40 million hepatitis B virus carriers accounting for 10-15% of the entire pool of HBV carriers of the world. [1] It is generally accepted, that the modality of transmission of hepatitis B virus in India is horizontal. However, the recent report of Dwivedi et al [2] , showing a high prevalence of replicative markers in India, suggest that there may be a significant role of vertical transmission as well. The significance of hepatitis B virus infection during pregnancy, derives in major part from its potential to be transmitted vertically. [3] Hepatitis B virus infection during pregnancy, is associated with a high risk of maternal complications, and has been reported as a leading cause of maternal mortality. [4] Ten percent of infants born to women with acute HBV infection, during the first trimester of pregnancy, are HBsAg positive at birth, and 80 to 90% of neonates become HBsAg positive without prophylactic therapy, if acute maternal infection develops during the third trimester of pregnancy. [5, 6] This strong possibility of vertical transmission, lends importance to diagnosing acute or chronic hepatitis B virus infection in pregnant women, and justifies mandatory antepartum serum HBsAg screening. [7] By doing so, previously unsuspected chronic hepatitis B virus infection is diagnosed in young, otherwise healthy, individuals. This has the added benefit of making it possible to refer them for appropriate antiviral therapy, before the development of significant liver damage and associated functional insufficiency. The prenatal screening of all pregnant women for HBsAg, helps to determine morbidity and mortality due to hepatitis B virus infection in pregnant women, and its effect on parturition. Furthermore, it also aids in reducing the incidence of perinatal transmission of hepatitis B virus, and formulating hepatitis B immunoprophylaxis to all new born infants of hepatitis B surface antigen positive mothers. Due to paucity of such type of study in this region of Maharashtra, the present study aimed to determine the seroprevalence of hepatitis B surface
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antigen among pregnant women.
Materials and Methods
The present retrospective hospital record-based study was conducted at a rural tertiary care teaching hospital in northern Maharashtra, India. Data was collected over a period of 4&1/2 years from January 2010 to June 2014. In this period, total 1815 women, in any trimester of pregnancy, with or without jaundice, and attending the antenatal clinic, were subjected to the study. After a complete general, systemic and obstetrical examination, blood samples were collected from pregnant women, after informed consent. The screening for HBsAg in all the serum samples collected, was performed using commercial kit based on the ELISA (Span Diagnostic Ltd, Surat, India), as per the manufacturer's instructions. Those found to be positive, were retested, and if found positive again, were declared HBsAg positive. The data of HBsAg was statistically analyzed with chi square test, and results were considered significant if P value was < 0.05.
Results
In total 1815 pregnant women included in the present study, the overall seroprevalence of HBsAg was found 1.15% (Table 1) . In regards to the seroprevalence of HBsAg in pregnant women, according to the included age groups, the highest seroprevalence rate of 1.87% was found in the age group of 20-24 years, and lowest of 0.45% in age group of 15-19 years (Table 1) . However, the seroprevalence of HBsAg in pregnant women, according to the age groups association, was not found significant statistically (P>0.05). The HBsAg seropositivity in different trimester of pregnancy, showed the increasing trend from first to third trimester of pregnancy, and highest seroprevalence of 1.50 % (14/928) was found during third trimester of pregnancy ( Table 2 ). The significant statistical association was not found between samples screened in different trimesters of pregnancy with HBsAg positivity (P>0.05).
Discussion
The prevalence of HBsAg varies widely in different parts of the India and its subpopulations, depending on a variety of inter-related historical, behavioural, environmental type of population studied, genetic factors, socioeconomic status and other risk factors. In India, the prevalence of HBsAg positivity in pregnant women has been reported to range from 0.61-6.3%. [2, [8] [9] [10] [11] In our study, the overall seroprevalence of HBsAg positivity in pregnant women (1.15%), was in agreement with a seroprevalence of 1.1% reported by Pande et al, [9] and comparable to the seroprevalence 0.9% reported by Dwivedi M et al [2] . Some of the studies from India, as carried out by Mittal et al [11] , Gill et al [12] , Nayak et al [13] and Khakhkhar Vipul et al [14] , reported higher seroprevalence rate of 6.3 %, 5%, 3.7% and 3.07% respectively, in comparison to our study. In few studies from India, as by S. Chatterjee et al [15] (0.82%) and Shazia Parveen S. et al [8] (0.61%), the seroprevalence rate reported were lower than the present study. The seroprevalence of hepatitis B in pregnant women varies from country to country. The prevalence of sero-positive HBsAg among pregnant women in our study can be also comparable with 1.6%, 1.47% and 1.37% as reported in some countries like Saudi Arabia [16] , Southeastern Turkey [17] and Pakistan [18] respectively. Regarding age, in the present study, high HBsAg seropositivity rate in pregnant women was found in age group 20-24 years, which was in agreement with the study of Dwivedi M et al and Khakhkhar Vipul et al. [2, 14] In relation to trimester of pregnancy, the maximum HBsAg seropositivity of 1.50 % during third trimester, as found in the present study, was in accordance with the findings of Khakhkhar Vipul et al. [14] However, The correlation of HBsAg seropositivity in selected age groups, and with trimesters of pregnancy in our study, was not found statistically significant (P>0.05).
Conclusion
The overall HBsAg seropositivity of 1.15% in pregnant women in this study recommends appropriate antenatal screening, proper preventive and timely interventional measures targeted at all the pregnant women, in order to to neonates. Furthermore, in particular, health education about modes of transmission of hepatitis B virus, and other risk factors, has to be given to all pregnant women.
